About TFF Pharmaceuticals
TFF Pharmaceuticals is a company based in Austin (United States) founded in 2018.. TFF Pharmaceuticals has raised $22.17 million across 5 funding rounds from investors including HHS, NIAID and Liquid Venture Partners. The company has 15 employees as of December 31, 2022. TFF Pharmaceuticals offers products and services including Biopharmaceutical Drugs. TFF Pharmaceuticals operates in a competitive market with competitors including MediciNova, Theravance Biopharma, Elastrin, Chance Pharmaceuticals and ReAlta Life Sciences, among others.
- Headquarter Austin, United States
- Employees 15 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Tff Pharmaceuticals, Inc.
-
Annual Revenue
$733.87 K48as on Dec 31, 2023
-
Net Profit
$-21.24 M33as on Dec 31, 2023
-
EBITDA
$-21.89 M31as on Dec 31, 2023
-
Total Equity Funding
$22.17 M (USD)
in 5 rounds
-
Latest Funding Round
$864.95 K (USD), Grant
Jul 03, 2023
-
Investors
HHS
& 2 more
-
Employee Count
15
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TFF Pharmaceuticals
TFF Pharmaceuticals offers a comprehensive portfolio of products and services, including Biopharmaceutical Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Focuses on clinical stage pharmaceutical innovations for research purposes
Unlock access to complete
Unlock access to complete
Funding Insights of TFF Pharmaceuticals
TFF Pharmaceuticals has successfully raised a total of $22.17M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $864.95 thousand completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $864,948
-
First Round
First Round
(03 Apr 2018)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Grant - TFF Pharmaceuticals | Valuation |
investors |
|
| Jun, 2023 | Amount | Grant - TFF Pharmaceuticals | Valuation |
investors |
|
| Aug, 2020 | Amount | Post-IPO - TFF Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TFF Pharmaceuticals
TFF Pharmaceuticals has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, NIAID and Liquid Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Liquid Venture Partners is engaged in assisting young companies with transformative technologies to go public through Nasdaq IPOs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TFF Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TFF Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tff Pharmaceuticals Comparisons
Competitors of TFF Pharmaceuticals
TFF Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediciNova, Theravance Biopharma, Elastrin, Chance Pharmaceuticals and ReAlta Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small-molecule therapeutics are developed for asthma, COPD, and neurologic diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for inflammatory and immunological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic targets related to arterial and lung diseases
|
|
| domain | founded_year | HQ Location |
Inhalation therapies for pulmonology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutic drugs for acute inflammatory and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tff Pharmaceuticals
Frequently Asked Questions about TFF Pharmaceuticals
When was TFF Pharmaceuticals founded?
TFF Pharmaceuticals was founded in 2018.
Where is TFF Pharmaceuticals located?
TFF Pharmaceuticals is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Who is the current CEO of TFF Pharmaceuticals?
Harlan Weisman is the current CEO of TFF Pharmaceuticals.
Is TFF Pharmaceuticals a funded company?
TFF Pharmaceuticals is a funded company, having raised a total of $22.17M across 5 funding rounds to date. The company's 1st funding round was a Post-IPO of $25.9M, raised on Apr 03, 2018.
How many employees does TFF Pharmaceuticals have?
As of Dec 31, 2022, the latest employee count at TFF Pharmaceuticals is 15.
What is the annual revenue of TFF Pharmaceuticals?
Annual revenue of TFF Pharmaceuticals is $733.87K as on Dec 31, 2023.
What does TFF Pharmaceuticals do?
TFF Pharmaceuticals was founded in 2018 in Austin, United States, focusing on the pharmaceutical sector. Proprietary thin-film freezing technology is employed to produce dry powder inhalers for respiratory drugs. This approach is applied to small molecules, biologics, and combination therapies targeting chronic respiratory conditions. Operations center on advancing inhalation delivery systems for improved drug administration.
Who are the top competitors of TFF Pharmaceuticals?
TFF Pharmaceuticals's top competitors include Theravance Biopharma, MediciNova and ReAlta Life Sciences.
What products or services does TFF Pharmaceuticals offer?
TFF Pharmaceuticals offers Biopharmaceutical Drugs.
Who are TFF Pharmaceuticals's investors?
TFF Pharmaceuticals has 3 investors. Key investors include HHS, NIAID, and Liquid Venture Partners.